Maham Fatima
2 min read
In This Article:
Elevance Health Inc. (NYSE:ELV) is one of the 8 Best Inexpensive Stocks to Buy Right Now. On June 9, Truist analyst David MacDonald slightly reduced the firm’s price target on Elevance Health from $510 to $500, while maintaining a Buy rating on the shares. Despite the adjustment, the analyst remains positive on Elevance Health’s substantial scale and local market share.
In Q1 2025, the company posted adjusted diluted EPS of $11.97, which showed over 10% year-over-year growth. For the full year, Elevance Health provided adjusted EPS guidance of $34.15 to $34.85. The company expanded its value-based oncology care model to Medicare Advantage in this quarter, following its success in the commercial sector. Elevance Health maintained strong retention rates in Medicare Advantage, supporting both margin and membership sustainability.
A medical professional working at a computer, utilizing the company's digital solutions to improve care quality for consumers.
Carelon Services also experienced growth and broadened relationships with external payers and launched new contracts in post-acute and behavioral health. The company’s acquisition of CareBridge further enhanced capabilities in home and community-based services and contributed to a reduction in ER visits and institutional stays. However, Elevance Health faced elevated cost trends in its Medicaid business.
Elevance Health Inc. (NYSE:ELV) is a health benefits company in the US. It operates through 4 segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. The company was formerly known as Anthem Inc. and changed its name to Elevance Health Inc. in June 2022.
While we acknowledge the potential of ELV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
Disclosure: None. This article is originally published at Insider Monkey.
